Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

A new class of weight-loss drugs touted as a revolutionary breakthrough in obesity management have received global attention, ...

We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...

The Only Way Is Essex star James Argent and his girlfriend Nicoline Artursson have opened up about their whirlwind romance ...

StudyFinds' Dr. Faith Coleman explains what happens when patients stop taking popular weight loss medications.

In a tweet he posted shortly before the election, Robert F. Kennedy Jr. took up arms against the Food and Drug Administration ...

The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will ...

Most people taking drugs like Ozempic and Wegovy have shed significant pounds. But obesity experts say that roughly 20% of ...

UPMC said increased medical utilization and rising pharmacy prices have resulted in a $371 million operating loss.

We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a ...